121 related articles for article (PubMed ID: 6590896)
1. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
[No Abstract] [Full Text] [Related]
2. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
3. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
5. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.
Kris MG; Pablo D; Gralla RJ; Burke MT; Prestifilippo J; Lewin D
Cancer Treat Rep; 1984; 68(7-8):1029-31. PubMed ID: 6744336
[TBL] [Abstract][Full Text] [Related]
6. A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration.
Ohsaka A; Kano Y; Sakamoto S; Kanzaki A; Hashimoto M; Yawata Y; Miura Y
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):7-17. PubMed ID: 2741652
[TBL] [Abstract][Full Text] [Related]
7. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
[TBL] [Abstract][Full Text] [Related]
8. Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Grozea PN; Fabian CJ; Dixon DO
Cancer Treat Rep; 1984; 68(7-8):963-7. PubMed ID: 6744347
[TBL] [Abstract][Full Text] [Related]
9. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
[TBL] [Abstract][Full Text] [Related]
10. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
11. [Remission induction in adult acute lymphocytic leukemia--use of vinca alkaloids and prednisolone alone].
Sampi K; Honda T; Hayashi Y; Hattori M
Rinsho Ketsueki; 1983 Dec; 24(12):1645-9. PubMed ID: 6584652
[No Abstract] [Full Text] [Related]
12. A phase II study of vindesine in patients with hematological malignancies.
Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of Vindesine in patients with hematological malignancy].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
[TBL] [Abstract][Full Text] [Related]
14. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
[TBL] [Abstract][Full Text] [Related]
15. [Vindesine, a new cytostatic agent from the vinca alkaloids].
Goldhirsch A; Joss R; Sonntag RW; Brunner KW
Dtsch Med Wochenschr; 1980 Jun; 105(26):931-5. PubMed ID: 6931709
[No Abstract] [Full Text] [Related]
16. [Hereditary spherocytosis presenting with acute lymphoblastic leukemia].
Ishida Y; Niino M; Matsuda H; Bandou S
Rinsho Ketsueki; 1987 Mar; 28(3):402-7. PubMed ID: 3475487
[No Abstract] [Full Text] [Related]
17. [Combination therapy of vinca alkaloids and nicardipine in non-Hodgkin's lymphoma with resistant to various antineoplastic agents].
Honda T; Sampi K; Hattori M
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2330-4. PubMed ID: 6639094
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of Vinca alkaloids.
Rosenthal RC
J Am Vet Med Assoc; 1981 Dec; 179(11):1084, 1086. PubMed ID: 6948802
[No Abstract] [Full Text] [Related]
19. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
Cersosimo RJ; Bromer R; Licciardello JT; Hong WK
Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
